Celularity Inc. announces exclusive manufacturing and commercial collaboration with Vesalius Longevity Labs Inc.

Celularity Inc. (CELU) entered into an exclusive manufacturing and commercial collaboration with Vesalius Longevity Labs Inc. for U.S.-based purification, processing, analytical testing, and manufacture of peptide active pharmaceutical ingredients under Vesalius's Peptual® brand. This partnership aims to establish a domestic supply platform and strengthen the peptide API supply chain. The announcement was made via a press release and an 8-K filing on October 29, 2026.